# Replimune Group, Inc. (REPL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Replimune Group, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2026 MD&A](/company/REPL/mda/fy2026/): filed 2026-06-29; accession 0001628280-26-045886 (https://www.sec.gov/Archives/edgar/data/1737953/000162828026045886/repl-20260331.htm); latest 10-K
- [FY 2025 MD&A](/company/REPL/mda/fy2025/): filed 2025-05-22; accession 0001737953-25-000009 (https://www.sec.gov/Archives/edgar/data/1737953/000173795325000009/repl-20250331.htm)
- [FY 2024 MD&A](/company/REPL/mda/fy2024/): filed 2024-05-16; accession 0001737953-24-000008 (https://www.sec.gov/Archives/edgar/data/1737953/000173795324000008/repl-20240331.htm)
- [FY 2023 MD&A](/company/REPL/mda/fy2023/): filed 2023-05-18; accession 0001737953-23-000009 (https://www.sec.gov/Archives/edgar/data/1737953/000173795323000009/repl-20230331.htm)
- [FY 2022 MD&A](/company/REPL/mda/fy2022/): filed 2022-05-19; accession 0001737953-22-000010 (https://www.sec.gov/Archives/edgar/data/1737953/000173795322000010/repl-20220331.htm)

Back to /company/REPL/